Search results for "ETG"

showing 10 items of 45 documents

Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial

2017

Background Limited prospective studies have examined changes in non-alcoholic fatty-liver disease (NAFLD) related serum-metabolites and none the effects of NAFLD-reversion. We aimed to evaluate whether perturbations in metabolites indicate predisposition to NAFLD development and to assess the effects of NAFLD reversion on metabolite profiles. Methods A targeted liquid-chromatography tandem mass-spectrometry metabolic profiling (n = 453 metabolites) approach was applied, using serum from 45 subjects of the PREDIMED study, at baseline and after a median 3.8-year follow-up. NAFLD was determined using the hepatic steatosis index; with three groups classified and studied: Group 1, not characteri…

0301 basic medicinemedicine.medical_specialtyEndocrinology Diabetes and MetabolismMetaboliteMedicine (miscellaneous)lcsh:TX341-641Clinical nutritionBiology03 medical and health scienceschemistry.chemical_compoundFetge--MalaltiesInternal medicineLipid biosynthesisHepatic lipotoxicitymedicineMetabolomicsProspective cohort studylcsh:RC620-627Nutrition and DieteticsFatty acid metabolismResearchFatty livernutritional and metabolic diseasesmedicine.diseasedigestive system diseaseslcsh:Nutritional diseases. Deficiency diseases030104 developmental biologyEndocrinologychemistryLipotoxicityFatty acid metabolismSteatosislcsh:Nutrition. Foods and food supplyNon-alcoholic fatty liver diseaseNutrition & Metabolism
researchProduct

Puntura percutanea eco-guidata e puntura TC-guidata di neoformazioni endotoraciche

2004

Puntura percutanea eco-guidata e puntura TC-guidata di neoformazioni endotoraciche Data: 2004 Dettaglio tipologia d'Ateneo: 3a - Articoli su riviste ISI (anche on line)

Settore MED/21 - Chirurgia ToracicabiopsiaETGpuntura tc guidataSettore MED/36 - Diagnostica Per Immagini E RadioterapiaTC
researchProduct

Condiciones morales del médico y sus deberes y derechos ante la sociedad : discurso leído en la Academia Científico-Literaria de la Juventud Católica…

1892

Metges Discursos acadèmics. lemac
researchProduct

Survival trends for primary liver cancer, 1995–2009: analysis of individual data for 578,740 patients from 187 population-based registries in 36 coun…

2019

CONCORD Working Group Members: Africa—Algeria: S Bouzbid (Registre du Cancer d’Annaba); M Hamdi-Chérif*, Z Zaidi (Registre du Cancer de Sétif); Gambia: R Swaminathan (National Cancer Registry); Lesotho: SH Nortje (Children’s Haematology Oncology Clinics - Lesotho); Libya: MM El Mistiri (Benghazi Cancer Registry); Mali: S Bayo, B Malle (Kankou Moussa University); Mauritius: SS Manraj, R Sewpaul-Sungkur (Mauritius National Cancer Registry); Nigeria: A Fabowale, OJ Ogunbiyi* (Ibadan Cancer Registry); South Africa: D Bradshaw, NIM Somdyala (Eastern Cape Province Cancer Registry); DC Stefan (Umtata University); Tunisia: L Jaidane, M Mokni (Registre du Cancer du Centre Tunisien).
America (Central…

trendsFunnel plotmedicine.medical_specialtySurvivalPopulationPsychological interventionSocio-culturaleIntrahepatic bile ductsSettore MED/42 - Igiene Generale E Applicataliver cancerhepatocellular carcinoma (HCC)SDG 3 - Good Health and Well-beingInternal medicinemedicinecancer registryeducationSupervivènciaeducation.field_of_studybusiness.industryFetge -- Càncer -- EstadístiquesCancerGeneral MedicineLiver -- Cancer -- Statisticsmedicine.diseasetrendInvasive Malignant NeoplasmHepatocellular carcinomainternational/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingLiver cancerbusinesscholangiocarcinomaSurvival trends liver cancer hepatocellular carcinoma (HCC) cholangiocarcinoma cancer registry international
researchProduct

Els Practicants de la medicina en la creació del Regne de València (1238-1300)

2009

The figure of king Jaume I the Conqueror is well-known, but few times his fundamental role when dealing with the first sanitary policies has been raised. Medicine, at the height of the 13th century, was experiencing a principal transformation that would mark its evolution during all the late Middle Ages. King Jaume I constituted progressively a model of doctor linked to university, and, at the same time, he favoured the establishment of a good number of medical assistants on valencian lands, which had just been conquered. Moreover, he created the first institutions dedicated to watch over the public health of the new Valencian society

MetgesSalut públicaMedicina Dret i legislacióHospitalsActes d'història de la ciència i de la tècnica
researchProduct

Historia de la adoración y vso de las santas imágenes, y de la imagen de la fuente de la salud ... / Por el Maestro Iayme Prades ...

1596

Sig. [signe]6, A-Ii8, Kk6 Escut reial xil. a la port. - Sols tres grav. xil.: als Preliminars, a la p. 326 (el mateix) i a la p. 369. - Capitals grav. - Ornaments tip. Text amb postil·les marginals. - Reclams

Imatges i ídols Obres anteriors a 1800Mare de Déu de la Font de la Salud Traiguera (Comunitat Valenciana) Obres anteriors a 1800DIG-BHHeretges cristians Obres anteriors a 1800
researchProduct

Antidotum contra diversas omnium fere seculorum haereses ..

1528

Sig. [alfa]-[gamma]6, a-z6, A-X6, Y4, Z6 Capitals grav. - Frisos Text amb postil·les marginals. - Reclams. - Errates de fol., del f.267 passa al 270

DIG-BHHeretges cristians Obres anteriors a 1800
researchProduct

Dietary Inflammatory Index and liver status in subjects with different adiposity levels within the PREDIMED trial.

2018

Summary Background & aims To assess the possible association between a validated Dietary Inflammatory Index (DII) and specific dietary components with suitable non-invasive markers of liver status in overweight and obese subjects within the PREDIMED study. Methods A cross-sectional study encompassing 794 randomized overweight and obese participants (mean ± SD age: 67.0 ± 5.0 y, 55% females) from the PREDIMED (PREvencion con DIeta MEDiterranea) trial was conducted. DII is a validated tool evaluating the effect of diet on six inflammatory biomarkers (IL-1b, IL-4, IL-6, IL-10, TNF-α and C-reactive protein). Furthermore, a validated 137-item food-frequency-questionnaire was used to obtain the i…

MaleMediterranean dietPhysiologyDiseaseFetge -- MalaltiesOverweightCritical Care and Intensive Care MedicineDiet Mediterranean0302 clinical medicineNon-alcoholic Fatty Liver DiseaseSurveys and QuestionnairesAdiposityNutrition and DieteticsMalalties del fetgeFatty liverMiddle AgedInflamacióDiet RecordsC-Reactive ProteinLiver030220 oncology & carcinogenesisObesitatDieta030211 gastroenterology & hepatologyFemalemedicine.symptommedicine.medical_specialtyInflammation03 medical and health sciencesInternal medicineNAFLDmedicineHumansObesityLiver diseasesAgedInflammationbusiness.industryTumor Necrosis Factor-alphaInterleukinsAdipose tissuesAnthropometryOverweightmedicine.diseasePredimedObesityDietTeixit adipósEndocrinologyCross-Sectional StudiesPatient CompliancebusinessBiomarkers
researchProduct

Martes à 24 de Mayo del año ... MDCXXII. En la Congregacion general de la Santa Romana y Vniuersal Inquisicion, que se hizo en el Palacio Apostolic…

1622

Tres grav. amb símbols papals a la part superior de la f.

Heretgia (Dret canonic) Obres anteriors a 1800Inquisició Obres anteriors a 1800
researchProduct

Assessing the impact of COVID-19 on liver cancer management (CERO-19)

2021

[Background & Aims] The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges to healthcare systems and it may have heavily impacted patients with liver cancer (LC). Herein, we evaluated whether the schedule of LC screening or procedures has been interrupted or delayed because of the COVID-19 pandemic.

Hepatocellular carcinomaLCmedicine.medical_treatment:diagnóstico::toma de decisiones clínicas [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS]NursesRC799-869Liver transplantationCholangiocarcinomaClinical trialsENS-CCAInterquartile rangeDecisió Presa dePandemic:Other subheadings::/diagnosis [Other subheadings]:virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES]CERO-19Pandèmia de COVID-19 2020-Immunology and AllergyiCCA intrahepatic cholangiocarcinomaCOVID-19 coronavirus disease 2019Liver Cancer Outcome in the COVID-19-pandemic ProjectSettore MED/12 - Gastroenterologiaddc:617IQRGastroenterologyBCLC Barcelona Clinic Liver Cancer:Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES]:neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias hepáticas [ENFERMEDADES]Diseases of the digestive system. GastroenterologyManagementClinical PracticeClinical trialEuropean Network for the Study of Cholangiocarcinoma:Diagnosis::Clinical Decision-Making [ANALYTICAL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT]Fetge - Malalties - DiagnòsticInterquartile rangeLiver cancerLiver cancerPROGRESSION-FREE SURVIVALLiver Cancermedicine.medical_specialtyCoronavirus disease 2019 (COVID-19):Otros calificadores::/diagnóstico [Otros calificadores]610 Medicine & health:Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Liver Neoplasms [DISEASES]LT liver transplantationArticleBarcelona Clinic Liver CancerInternal MedicinemedicineENS-CCA European Network for the Study of CholangiocarcinomaHepatologybusiness.industryCERO-19 Liver Cancer Outcome in the COVID-19-pandemic ProjectCOVID-19IQR Interquartile rangemedicine.diseaseBCLCClinical trialEmergency medicineObservational study610 Medizin und GesundheitbusinessHCC hepatocellular carcinomaLC liver cancerSARS-CoV-2 severe acute respiratory syndrome coronavirus-2
researchProduct